ArticleContemporary clinical trials communications2023

Anticoagulation in type 2 myocardial infarctions: Lessons learned from the rivaroxaban in type 2 myocardial infarctions feasibility trial.

Pishoy Gouda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.